Sort
326,823 grants matching “clinical trial”
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$2,702,555Shahin Lockman · Harvard School Of Public Health · UM1 · FY2019 · AI
GENE THERAPY FOR HEMOPHILIA AND CORONARY ARTERY DISEASE
$2,702,124Stanford University · U01 · FY2003 · HL
COG NCTN Network Group Operations Center - Administrative Core
$2,702,029Peter C Adamson · Children'S Hosp Of Philadelphia · U10 · FY2020 · CA
COG NCTN Network Group Operations Center
$2,702,029Richard Aplenc · Children'S Hosp Of Philadelphia · U10 · FY2020 · CA
ACTIV-1 TIME-LIMITED BIOSPECIMEN STORAGE AND RELATED SERVICES (COVID-19), OPTION QUANTITY 1 STATISTICAL SUPPORT, OPTION QUANTITY 2 BIOSPECIMEN ANALYSI
$2,701,936Sandra Butler · Technical Resources International, Inc. · N01 · FY2022 · TR
Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)
$2,701,914Sharon L. Ramey · Virginia Polytechnic Inst And St Univ · U01 · FY2021 · NS
Amyloid Pathology and Cognition in Normal Elderly
$2,701,818William E Klunk · University Of Pittsburgh At Pittsburgh · RF1 · FY2014 · AG
Integrating patient-specific clinical and biological factors towards individualizing utilization of proton and photon radiation therapy.
$2,701,684Theodore S Hong · Massachusetts General Hospital · P01 · FY2022 · CA
Preventing Alzheimer's Disease with Cognitive Training: The PACT Trial
$2,701,645Jerri Edwards · University Of South Florida · R56 · FY2018 · AG
Involvement Of Human Viruses Associated With Chronic Neurologic Disease
$2,701,530Steven Jacobson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences
$2,701,343Sharon Kujawa · Massachusetts Eye And Ear Infirmary · P50 · FY2022 · DC
COORDINATING CENTER--DIABETES INTERVENTION/COMPLICATIONS
$2,700,964Case Western Reserve University · N01 · FY2000 · DK
A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder
$2,700,832Steven M Cohen · Drug Delivery Company, Llc, The · UG3 · FY2020 · DA
Therapeutic Targeting of Vascular Subphenotypes of Lung Disease
$2,700,395Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · HL
DMID Clinical Trial Management
$2,700,366Fred Batzold · Ppd Development Lp · N01 · FY2010 · AI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$2,700,161Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Bone Marrow Grafting for Leukemia and Lymphoma
$2,700,000Robert S Negrin · Stanford University · P01 · FY2013 · CA
Bone Marrow Grafting for Leukemia and Lymphoma
$2,700,000Robert S Negrin · Stanford University · P01 · FY2015 · CA
Midwest Murine-Tissue Mapping Center (MM-TMC)
$2,700,000Paul D. Robbins · University Of Minnesota · U54 · FY2024 · AG
Midwest Murine-Tissue Mapping Center (MM-TMC)
$2,700,000David A Bernlohr · University Of Minnesota · U54 · FY2023 · AG
The KAPP-Sen Tissue Mapping Center Collaborative
$2,700,000George A Kuchel · University Of Connecticut Sch Of Med/Dnt · U54 · FY2025 · AG
CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse
$2,700,000Philip Iredale · Cerevel Therapeutics, Llc · UH3 · FY2023 · DA
Bone Marrow Grafting for Leukemia and Lymphoma
$2,700,000Robert S Negrin · Stanford University · P01 · FY2017 · CA
The KAPP-Sen Tissue Mapping Center Collaborative
$2,700,000George A Kuchel · University Of Connecticut Sch Of Med/Dnt · U54 · FY2024 · AG
The KAPP-Sen Tissue Mapping Center Collaborative
$2,700,000George A Kuchel · University Of Connecticut Sch Of Med/Dnt · U54 · FY2023 · AG